Comparison of simultaneous antegrade/vein graft cardioplegia with antegrade cardioplegia for myocardial protection

Adv Ther. 2006 Nov-Dec;23(6):869-77. doi: 10.1007/BF02850208.

Abstract

Antegrade cardioplegic delivery via the aorta ensures distribution of cardioplegic solution through open arteries, but distribution may not be adequate beyond a stenotic coronary artery. This potential problem can be overcome by direct delivery of cardioplegia via a vein graft. The purpose of this study was to compare simultaneous antegrade/vein graft cardioplegia with antegrade cardioplegia during coronary artery bypass surgery. Twenty patients were divided into 2 groups. In group 1, intermittent antegrade cardioplegia was provided (n=10). In group 2, intermittent antegrade cardioplegia was supplemented by antegrade perfusion of vein grafts after distal anastomoses were completed (n=10). Data on enzyme release and hemodynamics were obtained preoperatively, before the induction of anesthesia, just before cross-clamping, immediately after aortic unclamping, and at 1, 6, 12, 24, and 48 h after unclamping. Enzyme release (creatinine phosphokinase-isoenzyme MB, cardiac troponin I, myoglobin) was similar in both groups (P>.05). Furthermore, no significant difference was noted in the incidence of postoperative low cardiac output syndrome, perioperative myocardial infarction, or ventricular arrhythmia (P>.05). In conclusion, both techniques permitted rapid postoperative recovery of myocardial function. Supplementation of antegrade perfusion of vein grafts with antegrade cold blood cardioplegia offered no advantage to study patients.However, hemostasis of a distal anastomosis may be controlled by this technique.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Biomarkers
  • Bundle-Branch Block / prevention & control*
  • Cardioplegic Solutions / administration & dosage*
  • Comorbidity
  • Coronary Artery Bypass / adverse effects
  • Coronary Artery Bypass / methods*
  • Female
  • Heart Arrest, Induced / methods*
  • Humans
  • Male
  • Middle Aged
  • Myocardial Ischemia / prevention & control*
  • Prospective Studies

Substances

  • Biomarkers
  • Cardioplegic Solutions